Your browser doesn't support javascript.
loading
ACTivity as medicine In Oncology for Head and Neck (ACTIOHN): Protocol for a feasibility study investigating a patient-centred approach to exercise for people with head and neck cancer.
Midgley, Adrian W; Levy, Andrew R; Rogers, Simon N; Brooker, Rachel C; Bryant, Valerie; Cherry, Mary Gemma; Lane, Steven; Nugent, Michael M; Price, Ruth; Schache, Andrew G; Young, Bridget; Patterson, Joanne M.
Affiliation
  • Midgley AW; Department of Sport and Physical Activity, Edge Hill University, Ormskirk, United Kingdom.
  • Levy AR; Health Research Institute, Edge Hill University, Ormskirk, Lancashire, United Kingdom.
  • Rogers SN; Health Research Institute, Edge Hill University, Ormskirk, Lancashire, United Kingdom.
  • Brooker RC; Department of Psychology, Edge Hill University, Ormskirk, United Kingdom.
  • Bryant V; Arrowe Park Hospital, Wirral University Teaching Hospital NHS Foundation Trust, Liverpool, United Kingdom.
  • Cherry MG; Faculty of Health and Social Care, Edge Hill University, Ormskirk, United Kingdom.
  • Lane S; The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, United Kingdom.
  • Nugent MM; Cancer of Head and Neck Group Experience (CHANGE) Patient and Public Involvement Group, Sunderland Royal Hospital, Sunderland, United Kingdom.
  • Price R; Institute of Population Health, University of Liverpool, Liverpool, United Kingdom.
  • Schache AG; Institute of Infection, Veterinary, and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.
  • Young B; Oral and Maxillofacial Surgery, Sunderland Royal Hospital, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, United Kingdom.
  • Patterson JM; Liverpool Head and Neck Centre, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom.
PLoS One ; 18(8): e0289911, 2023.
Article in En | MEDLINE | ID: mdl-37624789
BACKGROUND AND AIM: Attempts at personalisation of exercise programmes in head and neck cancer (HaNC) have been limited. The main aim of the present study is to investigate the feasibility and acceptability of introducing a remotely delivered, fully personalised, collaborative, and flexible approach to prescribing and delivering exercise programmes into the HaNC usual care pathway. METHODS: This is a single arm, feasibility study. Seventy patients diagnosed with HaNC will be recruited from two regional HaNC centres in the United Kingdom. Patients will undertake an 8-week exercise programme designed and delivered by cancer exercise specialists. The exercise programme will start any time between the time of diagnosis and up to 8 weeks after completing treatment, depending on patient preference. The content of the exercise programme will be primarily based on patient needs, preferences, and goals, but guided by current physical activity guidelines for people with cancer. The primary outcome measure is retention to the study. Secondary quantitative outcomes are uptake to the exercise programme, different measures of exercise adherence, pre- and post-intervention assessments of fatigue (Multidimensional Fatigue Symptom Inventory-Short Form), quality of life (SF-36), physical activity levels (International Physical Activity Questionnaire-Short Form), and various components of physical fitness. The outcomes of the nested qualitative study are acceptability and feasibility of the intervention evaluated via interviews with patients, health care professionals, and the cancer exercise specialists. Intervention and participant fidelity will be determined using checklists and scrutiny of each patient's logbook and the cancer exercise specialists' meeting notes. Analysis of quantitative data will be via standard summary statistics. Qualitative data will be analysed using thematic analysis. EXPECTED RESULTS: This feasibility study will inform the design and conduct of a future randomised controlled trial. Success will be defined according to a traffic light system for identifying the appropriateness of progression to a randomised controlled trial. TRIAL REGISTRATION: International Standard Randomised Controlled Trial Number registry (ISRCTN82505455).
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Head and Neck Neoplasms Type of study: Clinical_trials / Guideline / Qualitative_research Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2023 Type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Head and Neck Neoplasms Type of study: Clinical_trials / Guideline / Qualitative_research Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2023 Type: Article Affiliation country: United kingdom